Jazz Pharmaceuticals (JAZZ) Current Deferred Revenue (2010 - 2023)
Jazz Pharmaceuticals (JAZZ) posted Current Deferred Revenue of $4,000 for Q3 2023, down 99.5% from $871,000 a year earlier and unchanged from the prior quarter.
Jazz Pharmaceuticals (JAZZ) Current Deferred Revenue (2010 - 2023) Analysis & Trends
At the end of FY2022, Jazz Pharmaceuticals' Current Deferred Revenue came in at $463,000, down 77.9% from FY2021.
- Annual Current Deferred Revenue has declined for five consecutive years, with a five-year compound annual growth rate of -44.3% (FY2017 to FY2022).
- In prior years, Jazz Pharmaceuticals' Current Deferred Revenue was $2.09 million in FY2021 (-17.8%), $2.55 million in FY2020 (-46.1%), $4.72 million in FY2019 (-12.8%) and $5.41 million in FY2018 (-37.2%).
- Quarterly Current Deferred Revenue has run from a low of $4,000 in Q1 2023 to a high of $5.41 million in Q4 2018 over five years.
- On a year-over-year basis, Current Deferred Revenue has declined in each of the last 23 quarters, with an average decline of 66.6% over the last eight quarters.
- Across the past five years, year-over-year decline in Current Deferred Revenue ran from 11.5% in Q1 2020 to 99.8% in Q1 2023.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $4,000 (Q2 2023), $4,000 (Q1 2023) and $463,000 (Q4 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Jazz Pharmaceuticals | 15.03 Bn | 8.85 Bn | 1.09 Bn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 4,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 463,000.00 |
| Sep 30, 2022 | 871,000.00 |
| Jun 30, 2022 | 1.28 Mn |
| Mar 31, 2022 | 1.69 Mn |
| Dec 31, 2021 | 2.09 Mn |
| Sep 30, 2021 | 2.27 Mn |
| Jun 30, 2021 | 2.44 Mn |
| Mar 31, 2021 | 2.37 Mn |
| Dec 31, 2020 | 2.55 Mn |
| Sep 30, 2020 | 3.09 Mn |
| Jun 30, 2020 | 3.63 Mn |
| Mar 31, 2020 | 4.18 Mn |
| Dec 31, 2019 | 4.72 Mn |
| Sep 30, 2019 | 4.72 Mn |
| Jun 30, 2019 | 4.72 Mn |
| Mar 31, 2019 | 4.72 Mn |
| Dec 31, 2018 | 5.41 Mn |
Jazz Pharmaceuticals Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=JAZZ&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "JAZZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=JAZZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();